Stereotaxis (STXS) Cash from Operations Growth (1y) (2011 - 2026)
Stereotaxis (STXS) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.58 Bn | 121.36 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 44.90 Bn | 44.08 Bn | 2.15 Bn | 428.92% |
| 3 | Alcon | 32.95 Bn | 31.29 Bn | 1.53 Bn | - |
| 4 | Medline | 32.83 Bn | 30.59 Bn | 1.84 Bn | -39.59% |
| 5 | Resmed | 29.38 Bn | 27.72 Bn | 890.98 Mn | -4.24% |
| 6 | West Pharmaceutical Services | 23.41 Bn | 22.98 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 14.08 Bn | 13.52 Bn | 1.10 Bn | -751.72% |
| 8 | Cooper Companies | 13.79 Bn | 13.66 Bn | 735.40 Mn | 90.02% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 186.74% |
| 10 | Stereotaxis | 132.02 Mn | 117.40 Mn | 3.79 Mn | -93.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.48% |
| Dec 31, 2025 | -413.51% |
| Sep 30, 2025 | 2.89% |
| Jun 30, 2025 | -20.89% |
| Mar 31, 2025 | 24.17% |
| Dec 31, 2024 | 151.91% |
| Sep 30, 2024 | -347.67% |
| Jun 30, 2024 | -5.36% |
| Mar 31, 2024 | 16.27% |
| Dec 31, 2023 | 4.43% |
| Sep 30, 2023 | 61.82% |
| Jun 30, 2023 | -157.78% |
| Mar 31, 2023 | -27.77% |
| Dec 31, 2022 | -109.35% |
| Sep 30, 2022 | -73.97% |
| Jun 30, 2022 | -3,444.12% |
| Mar 31, 2022 | -619.02% |
| Dec 31, 2021 | -495.83% |
| Sep 30, 2021 | -201.46% |
| Jun 30, 2021 | 102.90% |